Little House Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.09M Buy
5,078
+177
+4% +$181K 1.37% 24
2026
Q1
$4.51M Buy
4,901
+8
+0.2% +$8.11K 1.16% 28
2025
Q4
$5.26M Buy
4,893
+151
+3% +$144K 1.32% 25
2025
Q3
$3.62M Sell
4,742
-8
-0.2% -$5.95K 0.83% 37
2025
Q2
$3.7M Sell
4,750
-141
-3% -$110K 0.93% 33
2025
Q1
$4.04M Buy
4,891
+1,266
+35% +$1.05M 1.11% 29
2024
Q4
$2.8M Sell
3,625
-19
-0.5% -$15.7K 0.8% 32
2024
Q3
$3.23M Sell
3,644
-5
-0.1% -$4.5K 0.93% 32
2024
Q2
$3.3M Buy
3,649
+146
+4% +$117K 1.03% 29
2024
Q1
$2.73M Buy
3,503
+988
+39% +$703K 0.9% 29
2023
Q4
$1.47M Buy
2,515
+1,158
+85% +$676K 0.53% 53
2023
Q3
$729K Buy
+1,357
New +$699K 0.3% 82
2023
Q1
Sell
-947
Closed -$346K 122
2022
Q4
$346K Buy
+947
New +$336K 0.17% 97
2019
Q2
Sell
-682
Closed -$88K 201
2019
Q1
$88K Buy
+682
New +$82.9K 0.07% 138

Other funds holding LLY

Little House Capital's LLY Position: Q2 2026 in Review

Little House Capital increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $181K and bringing the position to 5,078 shares worth $6.09M. The position accounts for 1.37% of the portfolio, ranked #24.

Little House Capital first reported a position in LLY in Q1 2019 and has held it in 14 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Little House Capital held 5,078 shares of Eli Lilly worth $6.09M as of Q2 2026.
  • Little House Capital bought 177 Eli Lilly shares in Q2 2026, an estimated $181K.
  • Eli Lilly made up 1.37% of Little House Capital's portfolio in Q2 2026, its #24 holding.
  • Little House Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 14 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.